Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Metastasis02:30

Metastasis

6.8K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.8K
Metastasis02:30

Metastasis

3.8K
3.8K
Tumor Progression02:07

Tumor Progression

7.8K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.8K
The Tumor Microenvironment02:17

The Tumor Microenvironment

8.1K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.1K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

6.3K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.3K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

L1CAM signaling through planar cell polarity drives SOX2 expression and lung adenocarcinoma metastasis.

Nature communications·2026
Same author

Tumor sialylation regulates G-CSF stability and promotes neutrophil-mediated immunosuppression in breast cancer.

Nature communications·2026
Same author

Metastasis as a Multiorgan Disease: Toward Organ-Informed Precision Oncology.

Cancer discovery·2026
Same author

Development of Antibody-Drug Conjugates Targeting L1CAM to Treat Metastatic Cancer.

Molecular cancer therapeutics·2026
Same author

TGFβ induces an atypical EMT to evade immune mechanosurveillance in lung adenocarcinoma dormant metastasis.

Nature cancer·2026
Same author

Mechanisms of resistance to VHL loss-induced genetic and pharmacological vulnerabilities.

EMBO molecular medicine·2025

関連する実験動画

Updated: Mar 26, 2026

The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues
07:39

The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues

Published on: June 16, 2018

10.0K

循環する腫瘍細胞による転移性コロニー化

Joan Massagué1, Anna C Obenauf1,2

  • 1Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York 10065, USA.

Nature
|January 22, 2016
PubMed
まとめ

癌細胞の転移は 複雑なプロセスで 多くの障害があります これらのメカニズムの理解は 癌の転移に対する より良い治療法の開発に不可欠です

科学分野:

  • 腫瘍学
  • 癌 生物学
  • 細胞 と 分子 医学

背景:

  • 転移はがんによる死亡の主な原因です.
  • 循環する腫瘍細胞 (CTC) は,転移の過程で多くの課題に直面します.
  • 現在の治療法は 既成の転移に対して 効果的でないことが多い.

研究 の 目的:

  • 腫瘍細胞による臓器の遠隔植民を成功させる多面的なメカニズムを解明する.
  • 治療対象となる転移過程の重要な決定因子を特定する.
  • 転移した癌の予防と治療の戦略を改善する.

主な方法:

  • 組織浸透,免疫回避,ニッチ適応,休眠,再活性化を含む転移の連続的なステップを調査した.
  • 循環する腫瘍細胞が 直面する生物学的障壁を分析した
  • 転移の過程で生じる 不効率性を理解することに焦点を当てました

主要な成果:

  • 転移は非常に非効率的なプロセスで 複数の重要なチェックポイントがあります
  • 植民を成功させるには 重要な生物学的・免疫学的障害を 克服する必要があります
  • 腫瘍細胞が潜伏した種として生き残り その後の成長が重要な段階です

さらに関連する動画

Lung Tumor Cell Recruitment Assay
04:28

Lung Tumor Cell Recruitment Assay

Published on: February 26, 2019

6.1K
Micromanipulation of Circulating Tumor Cells for Downstream Molecular Analysis and Metastatic Potential Assessment
05:17

Micromanipulation of Circulating Tumor Cells for Downstream Molecular Analysis and Metastatic Potential Assessment

Published on: May 14, 2019

9.2K

関連する実験動画

Last Updated: Mar 26, 2026

The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues
07:39

The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues

Published on: June 16, 2018

10.0K
Lung Tumor Cell Recruitment Assay
04:28

Lung Tumor Cell Recruitment Assay

Published on: February 26, 2019

6.1K
Micromanipulation of Circulating Tumor Cells for Downstream Molecular Analysis and Metastatic Potential Assessment
05:17

Micromanipulation of Circulating Tumor Cells for Downstream Molecular Analysis and Metastatic Potential Assessment

Published on: May 14, 2019

9.2K

結論:

  • 臨床的進歩のために,転移のより深いメカニズムを理解することは不可欠です.
  • 循環中の腫瘍細胞が直面する 特定の障害をターゲットにすることで 転移を妨げる可能性があります
  • 転移性疾患に対するより効果的な治療法を開発するには,知識の向上が不可欠です.